Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://deweywmhd324150.smblogsites.com/39080540/trelaglutide-exploring-a-new-option-for-chronic-diseases